Artificial tear studied as contact lens lubricant

Article

The benefits of an artificial tear drop that commonly is used to help relieve symptoms of dry eye may extend to contact lens wearers who experience dryness and discomfort caused by their CLs.

A double-masked, randomized, multicenter, parallel-design clinical trial was performed to assess the suitability and acceptance of an artificial tear by wearers of hydrogel, silicone hydrogel, and rigid gas-permeable CLs. An overview of the results was outlined by Joseph G. Vehige, OD, senior director, Consumer Eye Care Research and Development, Allergan.

Of the total subjects (n = 245), 166 subjects were randomly assigned to receive an artificial tear product of 0.5% carboxymethylcellulose and 0.9% glycerin (Refresh Optive Lubricant Eye Drops, Allergan), and 79 subjects received a lens rewetter solution of 0.5% carboxymethylcellulose (Refresh Contacts, Allergan). The subjects were instructed to use 1 to 2 drops of their respective products q.i.d. for 3 months.

Completion rates

The researchers studied completion rates in both groups and used questionnaires to assess any symptoms, problems, or complaints. They also conducted slit lamp examinations and lens-corrected Snellen acuity tests at baseline and at days 7 through 90.

Completion rates in both groups were high: 93.4% among the subjects using artificial tears, and 94.9% among those using the lens rewetter. There was an increase or no change in lens-corrected Snellen acuity at day 90 in 87.1% of the eyes of the artificial tear group (270/310) and 88.3% of the eyes of subjects using the lens rewetter (132/150).

Slit lamp examinations revealed little change from baseline for all lens types. At all visits through day 90, corneal staining was Grade 2 (mild) or less in all eyes except for one eye in the rewetter group. Overall, there were three reports from two subjects in the artificial tears group and two subjects in the lens rewetter group that reached Grade 3 for any slit lamp finding.

These findings would not be uncommon in any CL population of the study's size, regardless of eye drop or rewetter use or non-use, Dr. Vehige said.

Recent Videos
Bonnie An Henderson in an interview for the EnVision Summit
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
© 2024 MJH Life Sciences

All rights reserved.